PharmaShots | Incisive News in 3 Shots

Subscribe Now

Saghmos Therapeutics

Saghmos Therapeutics Receives the US Patent for ST-62516 to Reduce the Risk of Acute Kidney Injury

Saghmos Therapeutics Receives the US Patent for ST-62516 to Reduce the Risk of Acute Kidney Injury

June 6, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us